Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8972 |
High Similarity |
NPD8836 |
Approved |
0.8136 |
Intermediate Similarity |
NPD8831 |
Approved |
0.8136 |
Intermediate Similarity |
NPD8833 |
Approved |
0.7481 |
Intermediate Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD8861 |
Approved |
0.7414 |
Intermediate Similarity |
NPD8862 |
Approved |
0.7414 |
Intermediate Similarity |
NPD8859 |
Approved |
0.7388 |
Intermediate Similarity |
NPD799 |
Phase 1 |
0.7385 |
Intermediate Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7217 |
Intermediate Similarity |
NPD9194 |
Approved |
0.7217 |
Intermediate Similarity |
NPD9193 |
Approved |
0.7077 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7018 |
Intermediate Similarity |
NPD8838 |
Approved |
0.6963 |
Remote Similarity |
NPD1058 |
Discontinued |
0.696 |
Remote Similarity |
NPD757 |
Phase 3 |
0.6917 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6866 |
Remote Similarity |
NPD248 |
Discontinued |
0.6772 |
Remote Similarity |
NPD9132 |
Discontinued |
0.6769 |
Remote Similarity |
NPD420 |
Discontinued |
0.6761 |
Remote Similarity |
NPD9704 |
Approved |
0.6731 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6718 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.6716 |
Remote Similarity |
NPD8832 |
Approved |
0.6715 |
Remote Similarity |
NPD1264 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.6642 |
Remote Similarity |
NPD8826 |
Approved |
0.6617 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6564 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6564 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6557 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.6544 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD8185 |
Discontinued |
0.6514 |
Remote Similarity |
NPD8186 |
Phase 1 |
0.6493 |
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |
0.6489 |
Remote Similarity |
NPD76 |
Approved |
0.6489 |
Remote Similarity |
NPD9289 |
Approved |
0.6489 |
Remote Similarity |
NPD9288 |
Approved |
0.6489 |
Remote Similarity |
NPD9292 |
Approved |
0.6474 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6466 |
Remote Similarity |
NPD306 |
Approved |
0.6452 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6434 |
Remote Similarity |
NPD3695 |
Approved |
0.6434 |
Remote Similarity |
NPD193 |
Suspended |
0.6434 |
Remote Similarity |
NPD3696 |
Approved |
0.6429 |
Remote Similarity |
NPD8827 |
Approved |
0.6423 |
Remote Similarity |
NPD341 |
Approved |
0.6423 |
Remote Similarity |
NPD340 |
Approved |
0.642 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6418 |
Remote Similarity |
NPD1734 |
Clinical (unspecified phase) |
0.6379 |
Remote Similarity |
NPD8565 |
Clinical (unspecified phase) |
0.6378 |
Remote Similarity |
NPD8955 |
Approved |
0.6378 |
Remote Similarity |
NPD8954 |
Approved |
0.6376 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.637 |
Remote Similarity |
NPD171 |
Discontinued |
0.6345 |
Remote Similarity |
NPD185 |
Approved |
0.6301 |
Remote Similarity |
NPD4240 |
Approved |
0.6277 |
Remote Similarity |
NPD300 |
Approved |
0.6266 |
Remote Similarity |
NPD2136 |
Approved |
0.6266 |
Remote Similarity |
NPD2135 |
Approved |
0.6266 |
Remote Similarity |
NPD2134 |
Approved |
0.6259 |
Remote Similarity |
NPD250 |
Approved |
0.6259 |
Remote Similarity |
NPD166 |
Approved |
0.6259 |
Remote Similarity |
NPD249 |
Approved |
0.6259 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6259 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.625 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.625 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.625 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD174 |
Discontinued |
0.6178 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6174 |
Remote Similarity |
NPD195 |
Approved |
0.6174 |
Remote Similarity |
NPD186 |
Discovery |
0.6165 |
Remote Similarity |
NPD9360 |
Approved |
0.6145 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.6144 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.6144 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.614 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.6129 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.6107 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6094 |
Remote Similarity |
NPD8571 |
Phase 3 |
0.6093 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.6083 |
Remote Similarity |
NPD9210 |
Phase 2 |
0.6065 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.6043 |
Remote Similarity |
NPD9366 |
Approved |
0.6028 |
Remote Similarity |
NPD1705 |
Discontinued |
0.6026 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6026 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.6015 |
Remote Similarity |
NPD163 |
Approved |
0.6014 |
Remote Similarity |
NPD2618 |
Phase 1 |
0.6013 |
Remote Similarity |
NPD283 |
Approved |
0.6 |
Remote Similarity |
NPD9628 |
Approved |
0.5935 |
Remote Similarity |
NPD242 |
Approved |
0.5935 |
Remote Similarity |
NPD3107 |
Discontinued |
0.5935 |
Remote Similarity |
NPD338 |
Approved |
0.5897 |
Remote Similarity |
NPD339 |
Approved |
0.5891 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.589 |
Remote Similarity |
NPD9133 |
Approved |
0.5867 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.5864 |
Remote Similarity |
NPD1313 |
Approved |
0.586 |
Remote Similarity |
NPD169 |
Phase 2 |
0.5856 |
Remote Similarity |
NPD2364 |
Suspended |
0.5849 |
Remote Similarity |
NPD1869 |
Phase 2 |
0.5838 |
Remote Similarity |
NPD207 |
Discontinued |
0.5833 |
Remote Similarity |
NPD9375 |
Discontinued |
0.5827 |
Remote Similarity |
NPD8566 |
Approved |
0.5823 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.5814 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.5813 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.58 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.58 |
Remote Similarity |
NPD1451 |
Approved |
0.5799 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.5795 |
Remote Similarity |
NPD2446 |
Approved |
0.5795 |
Remote Similarity |
NPD2445 |
Approved |
0.5789 |
Remote Similarity |
NPD9358 |
Approved |
0.5789 |
Remote Similarity |
NPD9373 |
Approved |
0.5789 |
Remote Similarity |
NPD9359 |
Approved |
0.5782 |
Remote Similarity |
NPD2602 |
Clinical (unspecified phase) |
0.578 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.5772 |
Remote Similarity |
NPD9101 |
Discontinued |
0.5766 |
Remote Similarity |
NPD580 |
Discontinued |
0.5765 |
Remote Similarity |
NPD3593 |
Approved |
0.5762 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.5756 |
Remote Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.574 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.5732 |
Remote Similarity |
NPD214 |
Approved |
0.5732 |
Remote Similarity |
NPD213 |
Clinical (unspecified phase) |
0.5732 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.5725 |
Remote Similarity |
NPD9071 |
Phase 3 |
0.5724 |
Remote Similarity |
NPD9627 |
Approved |
0.5723 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.5723 |
Remote Similarity |
NPD2793 |
Discontinued |
0.5704 |
Remote Similarity |
NPD9374 |
Approved |
0.5698 |
Remote Similarity |
NPD1692 |
Approved |
0.5695 |
Remote Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.5683 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.5676 |
Remote Similarity |
NPD1506 |
Discontinued |
0.5673 |
Remote Similarity |
NPD1895 |
Discontinued |
0.5671 |
Remote Similarity |
NPD1777 |
Approved |
0.5671 |
Remote Similarity |
NPD1776 |
Approved |
0.5664 |
Remote Similarity |
NPD2191 |
Discontinued |
0.5663 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.5659 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.5659 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.5652 |
Remote Similarity |
NPD307 |
Approved |
0.5644 |
Remote Similarity |
NPD418 |
Approved |
0.5636 |
Remote Similarity |
NPD1215 |
Discontinued |
0.5625 |
Remote Similarity |
NPD9571 |
Approved |
0.5625 |
Remote Similarity |
NPD217 |
Approved |
0.5625 |
Remote Similarity |
NPD219 |
Phase 3 |
0.5625 |
Remote Similarity |
NPD216 |
Approved |
0.5625 |
Remote Similarity |
NPD220 |
Clinical (unspecified phase) |
0.5625 |
Remote Similarity |
NPD218 |
Approved |
0.562 |
Remote Similarity |
NPD1368 |
Approved |
0.5618 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.5612 |
Remote Similarity |
NPD9409 |
Discontinued |
0.5602 |
Remote Similarity |
NPD2333 |
Discontinued |
0.5602
|
Remote Similarity |
NPD9582 |
Phase 3 |